Immuneering Corp (IMRX)
1.42
-0.06
(-4.05%)
USD |
NASDAQ |
Apr 30, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Immuneering Free Cash Flow: -49.31M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -49.31M |
| September 30, 2023 | -49.18M |
| June 30, 2023 | -48.11M |
| March 31, 2023 | -46.89M |
| December 31, 2022 | -44.84M |
| September 30, 2022 | -42.28M |
| June 30, 2022 | -40.31M |
| Date | Value |
|---|---|
| March 31, 2022 | -37.15M |
| December 31, 2021 | -30.91M |
| September 30, 2021 | -27.15M |
| June 30, 2021 | -21.60M |
| March 31, 2021 | -18.51M |
| December 31, 2020 | -14.67M |
Free Cash Flow Range, Past 5 Years
-49.31M
Minimum
Dec 2023
-14.67M
Maximum
Dec 2020
-36.23M
Average
-40.31M
Median
Jun 2022
Free Cash Flow Benchmarks
| Geron Corp | -168.57M |
| SELLAS Life Sciences Group Inc | -36.91M |
| Elicio Therapeutics Inc | -- |
| Vistagen Therapeutics Inc | -26.12M |
| ADMA Biologics Inc | 3.819M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.78M |
| Cash from Investing (Quarterly) | 3.133M |
| Cash from Financing (Quarterly) | 0.0078M |
| Free Cash Flow Per Share (Quarterly) | -0.408 |
| Free Cash Flow Yield | -122.2% |